Management of Peri-implant Mucositis With Ozone Water Jet: a Randomized Clinical Trial.

University of Pavia

Status: Completed

Conditions: Peri-implant Mucositis

Treatments: Other: Ozonized water; Other: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT04845087

2021-AQUALAB

Details and patient eligibility

About

The aim of this study is to assess if ozonized water can be used for the treatment of peri-implant mucositis in patients with dental implants.

Patients willl undergo professional dental hygiene also with the use of glycine powders, then they will be randomly divided into two groups:

• Trial Group: irrigation of peri-implant periodontium with mucositis with ozonized water.
• Placebo Group: irrigation of peri-implant periodontium with mucositis with water.

Periodontal indices will be recorded at the baseline, after 1 and 2 months. After 1 and 2 months, only glycine powders will be performed, together with ozonized water or water irrigation and the collection of periodontal indices.

Full description

The aim of this study is to assess if ozonized water can be used for the treatment of peri-implant mucositis in patients with dental implants.

Patients who respond to eligibility criteria and that will sign the informed consent will undergo a professional oral hygiene procedure.

Patients willl undergo professional dental hygiene also with the use of glycine powders. Then, glycine powders air-flow will be administered. Then they will be randomly divided into two groups:

• Trial Group: irrigation of peri-implant periodontium with mucositis with ozonized water.
• Placebo Group: irrigation of peri-implant periodontium with mucositis with water.

Periodontal indices will be recorded at the baseline, after 1 and 2 months. After 1 and 2 months, only glycine powder will be performed, together with ozonized water/water irrigation and the collection of periodontal indices.

Enrollment: 26 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Presence of one or more dental implants
• Presence of peri-implant mucositis at least at one implant
• Bleeding Score > 0

Exclusion criteria

• Patents without dental implants
• Presence of systemic diseases
• Patients with cardiac pacemaker

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

26 participants in 2 patient groups, including a placebo group

Trial Group

Experimental group

Description:

Patients from this group will receive treatment with ozonized water.

Treatment:

Other: Ozonized water

Placebo Group

Placebo Comparator group

Description:

Patients from this group will receive placebo with water.

Treatment:

Other: Placebo